Literature DB >> 33965562

Properties and reactivity of the folic acid and folate photoproduct 6-formylpterin.

Jean-François Goossens1, Xavier Thuru2, Christian Bailly3.   

Abstract

Folates (vitamin B9) are essential components of our diet and our gut microbiota. They are omnipresent in our cells and blood. Folates are necessary for DNA synthesis, methylation, and other vital bioprocesses. Folic acid (FA), as the synthetic form of folates, is largely found in supplements and fortified foods. FA and folate drugs are also extensively used as therapeutics. Therefore, we are continuously exposed to the pterin derivatives, and their photo-degradation products, such as 6-formylpterin (6-FPT) and pterin-6-carboxylic acid. During ultraviolet radiation, these two photolytic products generate reactive oxygen species (ROS) responsible for the cellular oxidative stress. 6-FPT can exhibit variable pro/anti-oxidative roles depending on the cell type and its environment (acting as a cell protector in normal cells, or as an enhancer of drug-induced cell death in cancer cells). The ROS-modulating capacity of 6-FPT is well-known, whereas its intrinsic reactivity has been much less investigated. Here, we have reviewed the properties of 6-FPT and highlighted its capacity to form covalent adducts with the ROS-scavenging drug edaravone (used to treat stroke and amyotrophic lateral sclerosis) as well as its implication in immune surveillance. 6-FPT and its analogue acetyl-6-FPT function as small molecule antigens, recognized by the major histocompatibility complex-related class I-like molecule, MR1, for presentation to mucosal-associated invariant T (MAIT) cells. As modulators of the MR1/MAIT machinery, 6-FPT derivatives could play a significant immuno-regulatory role in different diseases. This brief review shed light on the multiple properties and cellular activities of 6-FPT, well beyond its primary ROS-generating activity.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-formylpterin (PubChem CID: 135409352); Edaravone; Folate; Folic acid; Formylpterin; Immune surveillance; Reactive oxygen species

Mesh:

Substances:

Year:  2021        PMID: 33965562     DOI: 10.1016/j.freeradbiomed.2021.05.002

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  4 in total

1.  Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents.

Authors:  Natascha Leleu-Chavain; Romain Regnault; Hania Ahouari; Raphaël Le Biannic; Mostafa Kouach; Frédérique Klupsch; Romain Magnez; Hervé Vezin; Xavier Thuru; Christian Bailly; Jean-François Goossens; Régis Millet
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

Review 2.  Synthesis, Redox and Spectroscopic Properties of Pterin of Molybdenum Cofactors.

Authors:  Kyle J Colston; Partha Basu
Journal:  Molecules       Date:  2022-05-22       Impact factor: 4.927

Review 3.  Folic acid-induced animal model of kidney disease.

Authors:  Liang-Jun Yan
Journal:  Animal Model Exp Med       Date:  2021-11-24

4.  MR1-dependence of unmetabolized folic acid side-effects.

Authors:  Jeffry S Tang; Alissa Cait; Reuben M White; Homayon J Arabshahi; David O'Sullivan; Olivier Gasser
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.